Mouse models for the study of telomerase.

M A Blasco, H W Lee, M Rizen, D Hanahan, R DePinho, C W Greider
{"title":"Mouse models for the study of telomerase.","authors":"M A Blasco,&nbsp;H W Lee,&nbsp;M Rizen,&nbsp;D Hanahan,&nbsp;R DePinho,&nbsp;C W Greider","doi":"10.1002/9780470515433.ch11","DOIUrl":null,"url":null,"abstract":"<p><p>The ends of chromosomes, or telomeres, consist of short repeated sequences that are synthesized by a ribonucleoprotein-DNA polymerase called telomerase. The RNA component of telomerase is essential for enzyme activity. The maintenance of telomere length by telomerase has been proposed to be essential for cellular viability and to play an important role in cellular senescence and immortalization. We are interested in using the mouse as a model system for the study of telomerase. We studied telomerase activity and expression of the mouse telomerase RNA component (mTR) in two different transgenic mouse models of multistage tumorigenesis: models of islet cell carcinoma and squamous cell carcinoma. In both tumour models, telomerase activity was detected only in late-stage tumours, whereas the telomerase RNA was present at higher than normal levels in pre-neoplastic stages and increased further in late-stage tumours. However, the RNA levels did not parallel the amounts of telomerase activity detected, suggesting that regulation of telomerase activity does not correlate with the regulation of its RNA component. These results establish a direct correlation between progression to late-stage tumours and induction of telomerase activity, and suggest that the initial upregulation of telomerase RNA is an early event. To address the role of telomerase during normal mouse development and tumour formation, we have constructed a knockout mouse for the mouse telomerase RNA, mTR-/-. These mice and the cell lines derived from them are telomerase deficient.</p>","PeriodicalId":10218,"journal":{"name":"Ciba Foundation symposium","volume":"211 ","pages":"160-70; discussion 170-6"},"PeriodicalIF":0.0000,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"46","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ciba Foundation symposium","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/9780470515433.ch11","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 46

Abstract

The ends of chromosomes, or telomeres, consist of short repeated sequences that are synthesized by a ribonucleoprotein-DNA polymerase called telomerase. The RNA component of telomerase is essential for enzyme activity. The maintenance of telomere length by telomerase has been proposed to be essential for cellular viability and to play an important role in cellular senescence and immortalization. We are interested in using the mouse as a model system for the study of telomerase. We studied telomerase activity and expression of the mouse telomerase RNA component (mTR) in two different transgenic mouse models of multistage tumorigenesis: models of islet cell carcinoma and squamous cell carcinoma. In both tumour models, telomerase activity was detected only in late-stage tumours, whereas the telomerase RNA was present at higher than normal levels in pre-neoplastic stages and increased further in late-stage tumours. However, the RNA levels did not parallel the amounts of telomerase activity detected, suggesting that regulation of telomerase activity does not correlate with the regulation of its RNA component. These results establish a direct correlation between progression to late-stage tumours and induction of telomerase activity, and suggest that the initial upregulation of telomerase RNA is an early event. To address the role of telomerase during normal mouse development and tumour formation, we have constructed a knockout mouse for the mouse telomerase RNA, mTR-/-. These mice and the cell lines derived from them are telomerase deficient.

端粒酶研究的小鼠模型。
染色体的末端,即端粒,由一种被称为端粒酶的核糖核蛋白- dna聚合酶合成的短重复序列组成。端粒酶的RNA成分对酶的活性至关重要。端粒酶维持端粒长度被认为是细胞活力的必要条件,并在细胞衰老和永生中发挥重要作用。我们对使用小鼠作为端粒酶研究的模型系统很感兴趣。我们研究了端粒酶活性和小鼠端粒酶RNA组分(mTR)在两种不同的多阶段肿瘤发生小鼠模型中的表达:胰岛细胞癌和鳞状细胞癌。在这两种肿瘤模型中,端粒酶活性仅在晚期肿瘤中检测到,而端粒酶RNA在肿瘤前期高于正常水平,在晚期肿瘤中进一步增加。然而,RNA水平与检测到的端粒酶活性不平行,这表明端粒酶活性的调节与其RNA成分的调节无关。这些结果建立了晚期肿瘤进展与端粒酶活性诱导之间的直接关联,并表明端粒酶RNA的初始上调是一个早期事件。为了研究端粒酶在正常小鼠发育和肿瘤形成过程中的作用,我们构建了小鼠端粒酶RNA mTR-/-基因敲除小鼠。这些小鼠和来源于它们的细胞系端粒酶缺乏。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信